Shattuck Labs STTK
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$2.95M (6 inflow days, 14 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 41.2% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 5.98% to 10.71% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +2,409,389 | 3.4% |
| BlackRock | Mutual Fund | 2026/Q3 | +1,403,648 | 5.2% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +393,696 | 1.9% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +379,816 | 1.3% |
| Pinnacle Associates, Ltd. | Mutual Fund | 2026/Q3 | +228,337 | 2.1% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +192,170 | 0.2% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +174,652 | 3.3% |
| Connor, Clark & Lunn Investment Management Ltd. | Mutual Fund | 2026/Q3 | +173,086 | 0.5% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +4,425,270 | 15.8% |
| Frazier Life Sciences Management, LP | VC/PE Fund | 2026/Q3 | +3,750,000 | 3.7% |
| Deep Track Capital, LP | VC/PE Fund | 2026/Q3 | +3,706,734 | 3.6% |
| Adage Capital Management, L.P. | Hedge Fund | 2026/Q3 | +3,477,222 | 8.0% |
| BlackRock | Mutual Fund | 2026/Q3 | +3,425,004 | 3.9% |
| Wellington Management Group | Mutual Fund | 2026/Q3 | +1,767,938 | 1.7% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +1,069,516 | 3.7% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 5 Jul 2026 | Abhinav Shukla | Chief Technology Officer | Derivative Exercise and Retained | +12,153 | $3.57 | 75,295 |
| 1 Jul 2026 | Abhinav Shukla | Chief Technology Officer | Derivative Exercise and Sale | -410 | $7.01 | 75,295 |
| 30 Jun 2026 | Abhinav Shukla | Chief Technology Officer | Intent to Sell (Form 144) | -100 | $7.07 | – |
| 30 Jun 2026 | Abhinav Shukla | Chief Technology Officer | Derivative Exercise and Sale | -23,465 | $7.08 | 63,143 |
| 29 Jun 2026 | Arunthathy Pandite | Chief Medical Officer | Automatic Disposition | -30,000 | $7.01 | 136,219 |
| 29 Jun 2026 | Abhinav Shukla | Chief Technology Officer | Intent to Sell (Form 144) | -23,365 | $7.08 | – |
| 10 Jun 2026 | OrbiMed Advisors LLC | Open Market Derivative Acquisiti | +1,250,000 | $0.00 | 5,303,908 | |
| 8 Jun 2026 | Clay Siegall | Independent Director | Open Market Acquisition | +62,500 | $4.00 | 318,608 |
| 7 Jun 2026 | OrbiMed Advisors LLC | Other Derivative Acquisition | +18,439,788 | $0.00 | 5,095,575 | |
| 7 Jun 2026 | Mona Ashiya | Independent Director | Other Derivative Acquisition | +18,439,788 | $0.00 | 5,095,575 |
| 28 May 2026 | Clay Siegall | Independent Director | Other Derivative Acquisition | +81,000 | $5.95 | 81,000 |
| 28 May 2026 | Neil W. Gibson | Independent Director | Other Derivative Acquisition | +81,000 | $5.95 | 81,000 |
| 28 May 2026 | Mona Ashiya | Independent Director | Other Derivative Acquisition | +81,000 | $5.95 | 81,000 |
| 28 May 2026 | George Golumbeski | Independent Chairperson | Other Derivative Acquisition | +81,000 | $5.95 | 81,000 |
| 28 May 2026 | Helen Boudreau | Independent Director | Other Derivative Acquisition | +81,000 | $5.95 | 81,000 |
| 28 May 2026 | Daniel Baker | Independent Director | Other Derivative Acquisition | +81,000 | $5.95 | 81,000 |
| 21 May 2026 | Clay Siegall | Independent Director | Derivative Exercise and Retained | +128,054 | $1.08 | 256,108 |
| 20 May 2026 | Abhinav Shukla | Chief Technology Officer | Derivative Exercise and Retained | +5,122 | $1.08 | 63,143 |
| 14 May 2026 | Stephen Stout | General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer | Other Acquisition | +12,805 | $1.08 | 62,866 |
| 11 May 2026 | Taylor Schreiber | Chief Executive Officer | Derivative Exercise and Retained | +25,610 | $1.08 | 2,732,972 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 10,745,702 | 10.7% | 12.0 |
| 15 Oct 2026 | 10,440,338 | 10.4% | 7.2 |
| 30 Sep 2026 | 10,947,042 | 10.9% | 6.0 |
| 15 Sep 2026 | 6,808,662 | 6.8% | 8.4 |
| 31 Aug 2026 | 5,571,195 | 5.6% | 7.6 |
| 14 Aug 2026 | 6,006,320 | 6.0% | 5.8 |
No comments yet — be the first to weigh in on STTK.
Sign in to join the discussion.